HS-10542

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HS-10542, covering 2025-06-26 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria [Phase 1, Phase 2]